CVS Health (NYSE:CVS) is scheduled to release its fourth quarter results on February 20. The company had posted a 2.4% increase in sales to $47.3 billion with adjusted earnings reported at $1.73 per share in the previous earnings for Q3. This growth was primarily driven by higher prescription vol...
CVS Health (NYSE:CVS) is scheduled to release its fourth quarter results on February 20. The company had posted a 2.4% increase in sales to $47.3 billion with adjusted earnings reported at $1.73 per share in the previous earnings for Q3. This growth was primarily driven by higher prescription vol...
Share this Article
Recommended